AKT1 and amyotrophic lateral sclerosis: Additionally, ErbB4 mutations have been reported and confirmed in ALS/FTD and indicated that NRG1-ErbB4 activates many downstream pathway signals, including those of PI3K, Akt, and ERK1/2.